View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Softigel by Procaps

Contract Pharmaceutical Development Services and Commercial Manufacturing in Advanced Softgel Technologies

Softigel by Procaps is a leading provider of contract development and manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry.

Calle 80 # 78B – 201,

Softigel by Procaps is a leading provider of contract development and manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry.

Through its extensive capabilities and deep expertise in product development and softgel manufacturing, the firm helps different companies bring innovative products to market faster, offering patients and consumers an exceptional experience, higher preference and superior adherence to different therapies.

Softigel by Procaps has combined its advanced delivery technologies with proven formulation, manufacturing and regulatory expertise to become an integrated contract development and manufacturing organization (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, over-the-counter (OTC) and dietary supplements across both development and delivery.

Contract development and manufacturing services for the pharmaceutical industry

Softigel by Procaps focuses on difficult and challenging-to-manufacture drugs and is geared to detecting and materializing business opportunities in both generic and highly regulated markets, especially in niche segments where there is limited competition.

Softigel provides softgels, patented technologies, and single and multiple drug dosage systems.
Through its in-house facilities, Procaps offers cost-effective manufacture of pharma moulds, machines and spare parts.
Softigel provides patented technology for tablets coated with one or two gelatin colours, printed and un-printed.
In addition to softgel technologies, Procaps also offers other delivery systems that include powers, tablets and powders, hard gelatine capsules, nutritional gummies, ointments, gels and creams.
Procaps' production facilities are home to the development and manufacture of a comprehensive range of softgels, tablets, powders, creams and other drug delivery systems.
The company specialises in softgel technologies and offers access to other delivery systems.
Softigel has the flexibility to deliver diverse drug formulations to every corner of the world.
Softigel caters to multinational pharmaceutical clients, including Pfizer, GlaxoSmithKline, Sanofi-Aventis, Boehringer Ingelheim, and Bayer.
Softigel’s seven cutting-edge facilities house a fully integrated product development services (PDS) unit.

The company’s differentiating strengths enable it to move into more difficult-to-produce compounds, formulations, dosage forms and non-traditional manufacturing processes where few competitors can follow.

Softigel by Procaps is infused with a strong belief in the growing need for generic drugs, speciality pharma products and advanced delivery technologies. Working on developing opportunities with robust long-term partnerships from breakthrough technologies is its state of mind.

The company is uniquely qualified to meet the market’s needs for superior quality given its vertical integration and cutting-edge research and development (R&D).

Softigel by Procaps works with both large and small pharmaceutical companies that are seeking strategic, integrated partners that can offer advanced technologies and expertise, driving demand for integrated services from proof-of-concept to commercialisation.

Drug delivery technologies for pharmaceutical developers

Softigel by Procaps offers more than the traditional softgel technology. It offers a wide range of products ranging from a single unit dosage form to multiple delivery systems in a single dose. The company’s softgel-related technologies include:

  • Unigel™, a novel technology for fixed-dose combinations
  • Versagel™, soft chewable capsules that are free from animal derivatives
  • G-Tabs™, gelatin-coated tablets
  • Chewgels™, chewable soft capsules
  • Twistgels

Other technologies offered by Softigel by Procaps include:

  • Funtrition™, experts in nutraceutical gummies
  • Omega-3 high concentrates
  • Tablets
  • Powders
  • Prefilled syringes
  • Creams
  • Ointments
  • Gels
  • Hard gel capsules

Product development services from idea to commercialization

Softigel by Procaps’ cutting-edge softgel facilities house a fully integrated product development services (PDS) unit, which covers a wide range of product lifecycle phases from early development to commercialisation in the same plant.

The company’s state-of-the-art facility uses equipment replication from lab-scale through to small-scale good manufacturing practice (GMP) batches and full-scale commercial GMP.

Its R&D team offers customers access to formulation of simple or highly complex products, encapsulation in softgel dosage forms or other delivery systems, high or low potent active pharmaceutical ingredients (API), differentiated OTC products and nutritional supplements, traditional and unique delivery systems, and support and value during all stages.

Softigel by Procaps has proven expertise in technology transfers, product launches, product development and manufacturing technologies, helping its customers overcome formulation challenges.

The team works closely with customers to understand expectations and develop a regulatory strategy that guarantees the best quality, timely submissions and faster, more positive registration outcomes.

The company also has experience preparing submissions in electronic clinical trial document (eCTD) format, and provides support during the application phase, including annual reports and other post approval submissions.

Research and development services for advanced pharmaceutical formulations

A key factor in Softigel by Procaps’ market success is its R&D department, a team that is constantly working on the development of advanced formulas and innovative pharmaceutical technologies.

Procaps develops more than 50 new pharmaceutical, nutritional, cosmetics and veterinary products every year, which are all based on global industry trends and needs.

Quality certifications

Softigel holds a number of quality certifications, including:

  • EU GMP from the Medicines and Healthcare products Regulatory Agency (MHRA)
  • The US Food and Drug Administration (FDA)
  • Therapeutic Goods Administration (TGA) in Australia
  • Health Canada
  • GMP
  • International Stanidardisation Organisation (ISO) 9001
  • BASC
  • The National Administration of Medicines, Food and Medical Technology (ANMAT) of Argentina
  • Brazilian Health Regulatory Agency (ANVISA)
  • FDA Philippines
  • Ministry of Health (MOH) in Iran
  • Colombian Agriculture Institute (ICA)
  • HALAL-certified gelatin
  • Cofepris in Mexico
  • Organic Certified gummies facility

About Procaps Group

Procaps Group is a pharmaceutical company established over 40 years ago that has grown into a leading integrated pharma company with a presence in 14 countries and a product reach of over 50 markets modernizing oral drug delivery technology and manufacturing capabilities.

Our state-of-the-art manufacturing capabilities provide innovative delivery technologies protected by an extensive IP moat and supported by industry accolades such as the first FDA-approved pharmaceutical plant in South America for selling Rx products into the U.S.

Procaps Group today is the largest pharmaceutical contract development and manufacturing organization (CDMO) in Latin America and top 3 globally in terms of volume of softgel production capacity.


G-tabs™ is a patent-pending technology for tablets coated with one or two-toned colour gelatin, printed or not printed, widely used to eliminate unpleasant odours and/or tastes, improve ease of swallowing, prevent counterfeiting; and much more.


Versagel™ is a platform that has been built at Procaps from different standpoints such as: Formulation, R&D, Process, Product and Experience.


Expand your portfolio with new dosage forms that are convenient and filled with great flavor.


Softigel aims to deliver effective solutions to brands and consumers through Unigel™, the new smart softgel which lets multi-functional ingredients exist in one single dose.

Other Drug Delivery Forms

Softigel’s products use a variety of delivery methods, including tablets, powders, syrups, suspensions, creams, drops and emulsions.

Other Services

Softigel’s seven cutting-edge facilities house a fully integrated product development services (PDS) unit, which covers a wide range of product lifecycle phases from early development to commercialisation in the same plant, using equipment replication from lab scale, through small-scale good manufacturing practice (GMP) batches, until full-scale commercial GMP.


Twistgels allows access to a measured dose for topical and/or oral applications.


Funtrition® by Procaps is a leading provider of Contract Manufacturing services in advanced gummy technologies for the global nutraceutical industry.

Procaps Plants

Procaps is a multinational company with more than 35 years of expertise in manufacturing softgels and advanced new drug delivery techniques.

What’s Behind Vegetarian Soft Capsules

The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin alternatives.

Procaps Group Acquires First US-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit

Procaps Group, a leading integrated international healthcare and pharmaceutical company, today announced the closing of an asset purchase agreement to acquire an 86,000ft² pharmaceutical production facility located in West Palm Beach, Florida with production capacity of approximately 1.8 billion capsules per year for its iCDMO (integrated Contract and Manufacturing Organization) business unit, and is expected to increase Procaps Group’s product development capabilities by more than 70%.

13 January 2022

Softigel by Procaps Announces New Website Launch

Softigel by Procaps, a leading provider of contract development and manufacturing services in softgel advanced technologies for the pharmaceutical and nutraceutical industries, is proud to announce the launch of its newly revamped website.

20 October 2020

Join Softigel at CPhI

Softigel by Procaps will be attending CPhi North America´s second edition once again.

11 April 2018

Meet Softigel by Procaps at CPhI

Softigel by Procaps will be attending CPhI Worldwide in Paris from 7-9 October, where our team of experts will be available to discuss mutual opportunities.

22 September 2014

Procaps SA

Calle 80 # 78B – 201


Av. Patriotismo N° 229 Piso 7Ofic. N° 206
Col. San Pedro De Los Pinos
Deg. Benito Juarez
Mexico D.F.


Maipú 1210 Piso 8, oficina 817, C1006
Buenos Aires


Estrada dos Estudantes, 349
Sao Paulo


Sofgen Pharmaceuticals
1815 Griffin Road, Suite 404
Dania Beach
FL 33004
United States of America

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology